Industry News
Pharmaceutical Industry News
The FDA has signed off on an…
The FDA has signed off on an accelerated approval for Novo Nordisk's Wegovy to treat certain adults with metabolic-associated steatohepatitis. The green light tees up a likely showdown with Madrigal Pharmaceuticals' approved drug Rezdiffra in
China’s Biotech Is Cheaper and Faster Than America’s
China’s biotechnology sector has established a bright future by focusing not on breakthrough cures and treatments but on speed and efficiency.
Tonix Pharmaceuticals was founded…
Tonix Pharmaceuticals was founded in 2010 to develop and bring to market a drug for fibromyalgia. Fifteen years later, the New Jersey company has accomplished its mission with an FDA sign-off for Tonmya.
Earlier this summer, HHS Secretary…
Earlier this summer, HHS Secretary Robert F. Kennedy ousted all members of the CDC's vaccine advisory committee in an effort to remove industry influence. But according to a new study, industry-related conflicts of influence had
Every year, Fierce celebrates…
Every year, Fierce celebrates women making a powerful impact across biopharma and medtech. It’s time once again to make your suggestions for this year’s honorees.
The CDMO, formerly known as Oxford…
The CDMO, formerly known as Oxford Biomedica, sold more than 12.2 million ordinary shares for £4.31 ($5.85) per share. In addition, existing shareholders subscribed for 1.7 million shares at the same price, the company said.
After a 54% year-over-year sales…
After a 54% year-over-year sales increase for CGRP migraine drug Vyepti in the U.S., Lundbeck has raised its peak sales projection for the therapy in the key market.
Nearly a year after earning the…
Nearly a year after earning the first-ever FDA approval for a self-administered flu vaccine, AstraZeneca has kicked off a new service delivering its FluMist directly to consumers.
U.S. District Judge Gregory…
U.S. District Judge Gregory Williams concluded that two patents held by Lindis Biotech “are unenforceable due to inequitable conduct.” The decision negates the $50.3 million jury verdict Lindis won in December over allegations that Amgen’s
The FDA has approved a treatment…
The FDA has approved a treatment for recurrent respiratory papillomatosis for the first time. The agency has signed off on Precigen’s Papzimeos, a non-replicating adenoviral vector-based immunotherapy, which can eliminate the need for repeated surgical
The combination of Padcev and…
The combination of Padcev and Keytruda delivered a phase 3 win in muscle-invasive bladder cancer. China did not renew the conditional approval for a controversial Alzheimer's disease drug. Fosun Pharma is out-licensing its DPP1 inhibitor
Trump’s Tariffs Set to Hit Ireland, Where Drugmakers Play Tax Games
Manufacturing in Ireland has long helped many American drug companies pay lower taxes. But that strategy was designed for a world without President Trump’s tariffs.
While Sanofi originally had its…
While Sanofi originally had its eye on tolebrutinib when it purchased its partner Principia Biopharma for $3.7 billion, another of the biotech’s BTK inhibitors has made it across the FDA finish line first.
Eli Lilly said it has “intensified…
Eli Lilly said it has "intensified efforts to align prices across developed countries" in recent months. Besides a new U.K. price hike, Lilly said it may make other "necessary pricing adjustments" by Sept. 1.
An analysis of how cancer…
An analysis of how cancer drugmakers interact with oncologists found, perhaps unsurprisingly, that those interactions are dominated by therapies boasting a broad reach and targeting the most common cancers.
Despite a threat from President…
Despite a threat from President Donald Trump early last week that the administration's policy on pharmaceutical tariffs would come “within the next week or so,” his much-anticipated announcement is still “weeks away,” Reuters reports.
Chinese authorities did not renew…
Chinese authorities did not renew a conditional approval of Green Valley Pharmaceuticals’ controversial Alzheimer’s disease drug sodium oligomannate, also known as GV-971, according to online records.
President Donald Trump has inked a…
President Donald Trump has inked a new executive order calling on the HHS’ Administration for Strategic Preparedness and Response to identify and stockpile active pharmaceutical ingredients for roughly 26 medicines the agency deems essential.
Sana Biotechnology will turn to…
Sana Biotechnology will turn to CDMOs for manufacturing and pause its plant build-out in Bothell, Washington. The company opened the facility a year ago.
As it continues development of its…
As it continues development of its rademikibart for asthma and other inflammatory diseases, Connect Biopharma is teaming up with former pro football player Elbert “Ickey” Woods to drive asthma awareness across the U.S.